Hyun Soo Ko

Closest collaborators

The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Peter Gibbs · 4 shared papers, 2022–2025 · strength 0.79
   • Paper Current state of radiomic research in pancreatic cancer: focusing on study design and reproducibility of findings. DOI 10.1007/s00330-023-09653-6↗
   • Paper Skeletal muscle and visceral fat density are predictive imaging biomarkers for overall survival in patients with pancre… DOI 10.1016/j.suronc.2025.102251↗
   • Paper Real-world staging computed tomography scanning technique and important reporting discrepancies in pancreatic ductal ad… DOI 10.1111/ans.17787↗
2. Belinda Lee · 4 shared papers, 2022–2025 · strength 0.79
   • Paper Current state of radiomic research in pancreatic cancer: focusing on study design and reproducibility of findings. DOI 10.1007/s00330-023-09653-6↗
   • Paper Skeletal muscle and visceral fat density are predictive imaging biomarkers for overall survival in patients with pancre… DOI 10.1016/j.suronc.2025.102251↗
   • Paper Real-world staging computed tomography scanning technique and important reporting discrepancies in pancreatic ductal ad… DOI 10.1111/ans.17787↗
3. Benjamin N. J. Thomson · 3 shared papers, 2022–2025 · strength 0.55
   • Paper Skeletal muscle and visceral fat density are predictive imaging biomarkers for overall survival in patients with pancre… DOI 10.1016/j.suronc.2025.102251↗
   • Paper Real-world staging computed tomography scanning technique and important reporting discrepancies in pancreatic ductal ad… DOI 10.1111/ans.17787↗
   • Paper Impact of neoadjuvant FOLFIRINOX over upfront resection in borderline resectable pancreatic cancer-an international, mu… DOI 10.1016/j.esmorw.2023.100022↗
4. Benjamin P. T. Loveday · 2 shared papers, 2022–2024 · strength 0.32
   • Paper Real-world staging computed tomography scanning technique and important reporting discrepancies in pancreatic ductal ad… DOI 10.1111/ans.17787↗
   • Paper Impact of neoadjuvant FOLFIRINOX over upfront resection in borderline resectable pancreatic cancer-an international, mu… DOI 10.1016/j.esmorw.2023.100022↗
5. James Alex Malcolm · 1 shared paper, 2023 · strength 0.24
   • Paper Current state of radiomic research in pancreatic cancer: focusing on study design and reproducibility of findings. DOI 10.1007/s00330-023-09653-6↗
6. Sebastian Nowak · 1 shared paper, 2025 · strength 0.24
   • Paper Skeletal muscle and visceral fat density are predictive imaging biomarkers for overall survival in patients with pancre… DOI 10.1016/j.suronc.2025.102251↗
7. Julian Alexander Luetkens · 1 shared paper, 2025 · strength 0.24
   • Paper Skeletal muscle and visceral fat density are predictive imaging biomarkers for overall survival in patients with pancre… DOI 10.1016/j.suronc.2025.102251↗
8. Maike Theis · 1 shared paper, 2025 · strength 0.24
   • Paper Skeletal muscle and visceral fat density are predictive imaging biomarkers for overall survival in patients with pancre… DOI 10.1016/j.suronc.2025.102251↗
9. Alexander Grogan · 1 shared paper, 2022 · strength 0.16
   • Paper Real-world staging computed tomography scanning technique and important reporting discrepancies in pancreatic ductal ad… DOI 10.1111/ans.17787↗
10. Hui‐Li Wong · 1 shared paper, 2022 · strength 0.16
    • Paper Real-world staging computed tomography scanning technique and important reporting discrepancies in pancreatic ductal ad… DOI 10.1111/ans.17787↗
11. Adrian M. Fox · 1 shared paper, 2024 · strength 0.15
    • Paper Impact of neoadjuvant FOLFIRINOX over upfront resection in borderline resectable pancreatic cancer-an international, mu… DOI 10.1016/j.esmorw.2023.100022↗
12. Yat Hang To · 1 shared paper, 2024 · strength 0.15
    • Paper Impact of neoadjuvant FOLFIRINOX over upfront resection in borderline resectable pancreatic cancer-an international, mu… DOI 10.1016/j.esmorw.2023.100022↗
13. Sam Banks · 1 shared paper, 2024 · strength 0.15
    • Paper Impact of neoadjuvant FOLFIRINOX over upfront resection in borderline resectable pancreatic cancer-an international, mu… DOI 10.1016/j.esmorw.2023.100022↗
14. Adnan M. Nagrial · 1 shared paper, 2024 · strength 0.15
    • Paper Impact of neoadjuvant FOLFIRINOX over upfront resection in borderline resectable pancreatic cancer-an international, mu… DOI 10.1016/j.esmorw.2023.100022↗
15. Matthew Burge · 1 shared paper, 2024 · strength 0.15
    • Paper Impact of neoadjuvant FOLFIRINOX over upfront resection in borderline resectable pancreatic cancer-an international, mu… DOI 10.1016/j.esmorw.2023.100022↗
16. Mehrdad Nikfarjam · 1 shared paper, 2024 · strength 0.15
    • Paper Impact of neoadjuvant FOLFIRINOX over upfront resection in borderline resectable pancreatic cancer-an international, mu… DOI 10.1016/j.esmorw.2023.100022↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.